Shattuck Labs (STTK) Financials: History & Chart

Shattuck Labs, Inc.(STTK)

Biotechnology · Austin, TX

$5.93-0.57 (-8.77%)

Delayed quote: Oct 6, 2026, 3:40 PM EDT

About Shattuck Labs, Inc.

Shattuck Labs, Inc. operates as a biotechnology firm based in the United States, currently at the clinical development stage. Its core mission is to create innovative therapeutics designed to combat both cancer and autoimmune diseases. The company's leading experimental compound, SL-172154, is presently undergoing Phase 1 clinical assessment for the treatment of ovarian, fallopian tube, and peritoneal cancers. Furthermore, Shattuck Labs is advancing another product candidate, SL-279252, which is also in Phase 1 trials for patients afflicted with advanced solid tumors and lymphoma. Established in 2016, the company maintains its corporate headquarters in Austin, Texas.

Austin, TX

40 employees

www.shattucklabs.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Taylor H. Schreiber

View full financials

Financials

SEC Filings

Quarterly Income Statement (USD)

Swipe horizontally to review earlier periods. The line-item column stays pinned.

Quarterly Report	TTM	Quarter ended Jun 2026	Quarter ended Mar 2026	Quarter ended Dec 2025	Quarter ended Sep 2025	Quarter ended Jun 2025	Quarter ended Mar 2025	Quarter ended Dec 2024	Quarter ended Sep 2024
Revenue	1.00M	0.00	0.00	0.00	1.00M	0.00	0.00	0.00	3.00M
Cost of Goods Sold	8.51M	0.00	891K	0.00	7.62M	929K	936K	0.00	953K
Gross Profit	-7.51M	0.00	-891K	0.00	-6.62M	-929K	-936K	0.00	2.04M
Gross Profit Margin	-750.9%	N/A	N/A	N/A	-661.8%	N/A	N/A	N/A	68.2%
Total Operating Expenses	48.28M	16.16M	14.65M	13.37M	4.10M	12.10M	13.45M	19.64M	19.96M
Research & Development	39.32M	11.70M	10.95M	9.05M	7.62M	8.68M	9.92M	15.39M	16.31M
Selling, General & Administrative	17.47M	4.46M	4.60M	4.32M	4.10M	4.35M	4.47M	4.25M	4.60M
Operating Income (EBIT)	-55.79M	-16.16M	-15.54M	-13.37M	-10.72M	-13.03M	-14.39M	-19.64M	-17.92M
Operating Margin	-5578.7%	N/A	N/A	N/A	-1071.6%	N/A	N/A	N/A	-597.9%
Income Before Tax (EBT)	-52.57M	-15.15M	-14.77M	-12.59M	-10.06M	-12.46M	-13.70M	-18.68M	-16.68M
Interest Income	1.81M	1.03M	779K	N/A	N/A	N/A	N/A	5.17M	N/A
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Other Income/Expense	3.22M	1.00M	778K	778K	660K	574K	687K	962K	1.25M
Net Income	-52.57M	-15.15M	-14.77M	-12.59M	-10.06M	-12.46M	-13.70M	-18.68M	-16.68M
Income Tax Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Profit Margin	-5256.8%	N/A	N/A	N/A	-1005.6%	N/A	N/A	N/A	-556.4%
EBITDA	-51.67M	-14.76M	-14.65M	-12.46M	-9.80M	-12.10M	-13.45M	-18.70M	-16.97M
EBITDA Margin	-5167.3%	N/A	N/A	N/A	-979.9%	N/A	N/A	N/A	-566.1%
Depreciation & Amortization	4.11M	1.40M	891K	906K	917K	929K	936K	940K	953K
EPS Basic	-0.51	-0.12	-0.13	-0.12	-0.14	-0.24	-0.27	-0.37	-0.33
EPS Diluted	-0.51	-0.12	-0.13	-0.12	-0.14	-0.24	-0.27	-0.37	-0.33
Weighted Average Basic Shares	129.78M	129.78M	112.23M	103.78M	72.18M	51.00M	50.97M	50.84M	50.83M
Weighted Average Diluted Shares	129.78M	129.78M	112.23M	103.78M	72.18M	51.00M	50.97M	50.84M	50.83M

Annual Income Statement (USD)

Swipe horizontally to review earlier years. The line-item column stays pinned.

Annual Report	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018
Revenue	1.00M	5.72M	1.66M	652K	30.02M	9.93M	9.89M	22.44M
Cost of Goods Sold	2.95M	4.89M	4.04M	82.20M	1.38M	37.48M	29.22M	24.81M
Gross Profit	-1.95M	827K	-2.38M	-81.55M	28.64M	-27.55M	-19.33M	-2.37M
Gross Profit Margin	-195.1%	14.5%	-143.9%	-12507.2%	95.4%	-277.3%	-195.5%	-10.5%
Total Operating Expenses	49.56M	81.39M	89.57M	21.78M	73.91M	9.38M	5.74M	28.59M
Research & Development	35.27M	67.21M	74.31M	82.90M	56.56M	37.48M	29.22M	24.81M
Selling, General & Administrative	17.23M	19.08M	19.30M	19.68M	18.72M	9.38M	5.74M	3.78M
Operating Income (EBIT)	-51.51M	-80.57M	-91.96M	-103.33M	-45.27M	-36.93M	-25.07M	-6.15M
Operating Margin	-5150.8%	-1408.3%	-5549.6%	-15848.0%	-150.8%	-371.8%	-253.5%	-27.4%
Income Before Tax (EBT)	-48.81M	-75.41M	-87.30M	-101.94M	-44.97M	-36.60M	-23.98M	-7.39M
Interest Income	2.70M	5.17M	4.67M	1.59M	625K	549K	1.18M	966K
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	2.63M
Other Income/Expense	2.70M	5.16M	4.66M	1.38M	295K	328K	1.08M	-1.24M
Net Income	-48.81M	-75.41M	-87.30M	-101.94M	-44.97M	-36.60M	-23.98M	-7.39M
Income Tax Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Profit Margin	-4880.9%	-1318.1%	-5268.4%	-15635.7%	-149.8%	-368.5%	-242.6%	-32.9%
EBITDA	-47.82M	-76.74M	-87.92M	-100.26M	-43.89M	-36.31M	-24.53M	-5.89M
EBITDA Margin	-4782.0%	-1341.3%	-5305.7%	-15376.7%	-146.2%	-365.5%	-248.1%	-26.3%
Depreciation & Amortization	3.69M	3.83M	4.04M	3.07M	1.38M	618K	537K	255K
EPS Basic	-0.70	-1.49	-2.05	-2.41	-1.07	-0.88	-0.57	-0.49
EPS Diluted	-0.70	-1.49	-2.05	-2.41	-1.07	-0.88	-0.57	-0.49
Weighted Average Basic Shares	69.58M	50.76M	42.60M	42.38M	42.03M	41.77M	41.74M	15.04M
Weighted Average Diluted Shares	69.58M	50.76M	42.60M	42.38M	42.03M	41.77M	41.74M	15.04M

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.